Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gland Pharma has informed that Analyst/ Institutional Investor Meeting with the Company is held on 7th December, 2023, with Jennison Associates as one to one in person meeting.
The above information is a part of company’s filings submitted to BSE.